These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 36253067)

  • 1. PANoptosis: A Unique Innate Immune Inflammatory Cell Death Modality.
    Pandian N; Kanneganti TD
    J Immunol; 2022 Nov; 209(9):1625-1633. PubMed ID: 36253067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease.
    Chen W; Gullett JM; Tweedell RE; Kanneganti TD
    Eur J Immunol; 2023 Nov; 53(11):e2250235. PubMed ID: 36782083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining PANoptosis: Biochemical and Mechanistic Evaluation of Innate Immune Cell Death Activation.
    Tweedell RE; Hibler T; Kanneganti TD
    Curr Protoc; 2024 Jul; 4(7):e1112. PubMed ID: 39073015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Caspase Activation to Assess Innate Immune Cell Death.
    Han JH; Tweedell RE; Kanneganti TD
    J Vis Exp; 2023 Jan; (191):. PubMed ID: 36744800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of PANoptosis in cancer treatment.
    Xiong Y
    Biomed Pharmacother; 2023 Dec; 168():115696. PubMed ID: 37837884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. It's All in the PAN: Crosstalk, Plasticity, Redundancies, Switches, and Interconnectedness Encompassed by PANoptosis Underlying the Totality of Cell Death-Associated Biological Effects.
    Gullett JM; Tweedell RE; Kanneganti TD
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PANoptosis: Emerging mechanisms and disease implications.
    Qi Z; Zhu L; Wang K; Wang N
    Life Sci; 2023 Nov; 333():122158. PubMed ID: 37806654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes.
    Pandeya A; Kanneganti TD
    Trends Mol Med; 2024 Jan; 30(1):74-88. PubMed ID: 37977994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single cell analysis of PANoptosome cell death complexes through an expansion microscopy method.
    Wang Y; Pandian N; Han JH; Sundaram B; Lee S; Karki R; Guy CS; Kanneganti TD
    Cell Mol Life Sci; 2022 Sep; 79(10):531. PubMed ID: 36169732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis).
    Sharma BR; Karki R; Rajesh Y; Kanneganti TD
    J Biol Chem; 2023 Sep; 299(9):105141. PubMed ID: 37557956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways.
    Wang Y; Kanneganti TD
    Comput Struct Biotechnol J; 2021; 19():4641-4657. PubMed ID: 34504660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programming inflammatory cell death for therapy.
    Christgen S; Tweedell RE; Kanneganti TD
    Pharmacol Ther; 2022 Apr; 232():108010. PubMed ID: 34619283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PANoptosis: Mechanisms, biology, and role in disease.
    Sun X; Yang Y; Meng X; Li J; Liu X; Liu H
    Immunol Rev; 2024 Jan; 321(1):246-262. PubMed ID: 37823450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PANoptosome signaling and therapeutic implications in infection: central role for ZBP1 to activate the inflammasome and PANoptosis.
    Karki R; Kanneganti TD
    Curr Opin Immunol; 2023 Aug; 83():102348. PubMed ID: 37267644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current evidence and therapeutic implication of PANoptosis in cancer.
    Ocansey DKW; Qian F; Cai P; Ocansey S; Amoah S; Qian Y; Mao F
    Theranostics; 2024; 14(2):640-661. PubMed ID: 38169587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PANoptosis in Viral Infection: The Missing Puzzle Piece in the Cell Death Field.
    Nguyen LN; Kanneganti TD
    J Mol Biol; 2022 Feb; 434(4):167249. PubMed ID: 34537233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell death shapes cancer immunity: spotlighting PANoptosis.
    Gao L; Shay C; Teng Y
    J Exp Clin Cancer Res; 2024 Jun; 43(1):168. PubMed ID: 38877579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PANoptosis: a potential new target for programmed cell death in breast cancer treatment and prognosis.
    Liu X; Miao M; Sun J; Wu J; Qin X
    Apoptosis; 2024 Apr; 29(3-4):277-288. PubMed ID: 38001342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment.
    Zhu P; Ke ZR; Chen JX; Li SJ; Ma TL; Fan XL
    Front Immunol; 2023; 14():1120034. PubMed ID: 36845112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classical apoptotic stimulus, staurosporine, induces lytic inflammatory cell death, PANoptosis.
    Sarkar R; Choudhury SM; Kanneganti TD
    J Biol Chem; 2024 Aug; 300(9):107676. PubMed ID: 39151726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.